Association of GST M1 null polymorphism with Parkinson's disease in a Chilean population with a strong Amerindian genetic component

Neurosci Lett. 2007 May 17;418(2):181-5. doi: 10.1016/j.neulet.2007.03.024. Epub 2007 Mar 14.

Abstract

We have studied the association of a null mutation of Glutathione Transferase M1 (GST M1*0/0) with Parkinson's disease (MIM 168600) in a Chilean population with a strong Amerindian genetic component. We determined the genotype in 349 patients with idiopathic Parkinson's disease (174 female and 175 male; 66.84+/-10.7 years of age), and compared that to 611 controls (457 female and 254 male; 62+/-13.4 years of age). A significant association of the null mutation in GST M1 with Parkinson's disease was found (p=0.021), and the association was strongest in the earlier age range. An association of GSTM1*0/0 with Parkinson's disease supports the hypothesis that Glutathione Transferase M1 plays a role in protecting astrocytes against toxic dopamine oxidative metabolism, and most likely by preventing toxic one-electron reduction of aminochrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Aging / genetics
  • Aging / metabolism
  • Astrocytes / enzymology
  • Brain / enzymology
  • Brain / physiopathology
  • Chile / ethnology
  • Cytoprotection / genetics
  • DNA Mutational Analysis
  • Dopamine / metabolism
  • Female
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Genotype
  • Glutathione Transferase / genetics*
  • Humans
  • Indians, South American / ethnology
  • Indians, South American / genetics
  • Male
  • Middle Aged
  • Mutation
  • Oxidative Stress / genetics*
  • Parkinson Disease / enzymology*
  • Parkinson Disease / ethnology
  • Parkinson Disease / genetics*
  • Polymorphism, Genetic / genetics*

Substances

  • Glutathione Transferase
  • glutathione S-transferase M1
  • Dopamine